Does Dr. LORI ADELMANN have financial conflicts of interest?

Dr. LORI ADELMANN (ARNP) has received a total of $2,855 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $2,855 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. LORI ADELMANN?

According to CMS Open Payments data, Dr. LORI ADELMANN received funding from ZOLL SERVICES (A/K/A ZOLL LIFECOR ) ($650), ASTRAZENECA PHARMACEUTICALS ($637), and NOVARTIS PHARMACEUTICALS CORPORATION ($324).

Does Dr. LORI ADELMANN receive research grants or speaking fees?

Dr. LORI ADELMANN has received $2,855 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. LORI ADELMANN

ARNPReal-Time Hydrated

Specialty: Nurse Practitioner, Family

Practice Location: CORBIN, KY 40701

NPI Number: 1790889145

LIFETIME INDUSTRY VALUE

$2,855

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ADELMANN is a verified Nurse Practitioner, Family practitioner based in CORBIN, KY.

Between 2021 and 2025, Dr. ADELMANN had an overall industry promotional and research financial footprint of $2,855 as recorded in the federal CMS Open Payments database.

$2,855 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ADELMANN's primary funding source is ZOLL SERVICES (A/K/A ZOLL LIFECOR ), which accounts for $650 (representing 22.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ZOLL SERVICES (A/K/A ZOLL LIFECOR )

Rank 1

$650

22.8%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$637

22.3%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 3

$324

11.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.